申请人:Yasuma Tsuneo
公开号:US20070155808A1
公开(公告)日:2007-07-05
The present invention provides a novel compound having a GPR40 receptor function modulating action, which is useful as an insulin secretagogue, a drug for the prophylaxis or treatment of diabetes and the like.
A compound represented by the formula (I)
wherein each symbol is as defined in the specification, a salt thereof and a prodrug thereof have unexpectedly superior GPR40 receptor agonist activity and also show superior properties as a pharmaceutical product, such as stability and the like. Thus, they can be safe and useful drugs for the prophylaxis or treatment of GPR40 receptor related conditions or diseases in mammals.
本发明提供了一种新型化合物,具有GPR40受体功能调节作用,可用作胰岛素分泌剂,用于预防或治疗糖尿病等药物。化合物由式(I)表示,其中每个符号如规范中所定义,其盐和前药具有意外的优越的GPR40受体激动剂活性,并显示出卓越的药物产品特性,如稳定性等。因此,它们可以作为安全有效的药物,用于哺乳动物中预防或治疗与GPR40受体相关的疾病或病症。